Merck
CN
Search Within
Document Type

883-07-8

Applied Filters:
Keyword:'883-07-8'
Showing 1-9 of 9 results for "883-07-8" within Technical Documents
Data Sheet - P0081
J., Curr. Opin. Neurobiol., 17, 533-540 (2007). 3. Snipes, G.J., et al., Ann. N.Y. Acad. Sci., 883, 143- 151 (1999). 4. Quarles, R.H., Cell. Mol. Life Sci., 59, 1851-1871 (2002). 5. Kochański
Data Sheet - P0078
H., Cell. Mol. Life Sci., 59, 1851-1871 (2002). 3. Snipes, G. J., et al., Ann. NY Acad. Sci., 883, 143- 151 (1999). 4. Kochański, A., J. Appl. Genet., 47, 225-260 (2006). 5. Li, J., et al., J. Histochem
Data Sheet - C9464
characterization of bovine pancreatic bile salt-activated lipase. J. Biochem. (Tokyo), 125, 883-90 (1999). KAD,RBG,JWM,MAM 12/07-1 Sigma brand products are sold through Sigma-Aldrich, Inc. Sigma-Aldrich, Inc
Cholesterol Esterase (C3766)
and characterization of bovine pancreatic bile salt-activated lipase. J. Biochem. (Tokyo), 125, 883-90 (1999). 6. Hyun, J., et al., Cholesterol esterase – a polymeric enzyme. Biochem. Biophys. Res
Using a New, Fast Flow, Low Protein Binding Membrane for Sterile Filtration in Life Science Applications
BioPharmaceutical Division: Millipore Ireland B.V./Carrigtwohill, County Cork/Tel. (021) 883 666/Fax (021) 883 048 ITALY Milano: Millipore S.p.A./Via XI Febbraio, 99/20090 Vimodrone/Tel. (02) 25.07.81
Cytoskeletal Signaling Antibodies, Reagents and Kits
-PKCτ (Ser676) H WB APur Rb IgG 100 µL 07-883 anti-phospho-PKCτ (Ser695) H WB APur Rb IgG 100 µL 07-884 anti-phospho-PKCτ (Thr538) H WB APur Rb IgG 100 µL 07-885 Protein PKC τ, active KA
Apoptosis - Antibodies, Reagents and Kits
Anti-phospho-PKCθ (Ser676) H WB Rb IgG 100 µL 07-883 $309 Anti-phospho-PKCθ (Ser695) H WB Rb IgG 100 µL 07-884 $309 Anti-phospho-PKCθ (Thr538) H WB Rb IgG 100 µL 07-885 $309 PKCη Anti-phospho-PKCη
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
-PKCτ (Ser676) H WB APur Rb IgG 100 µL 07-883 Anti-phospho-PKCτ (Ser695) H WB APur Rb IgG 100 µL 07-884 Anti-phospho-PKCτ (Thr538) H WB APur Rb IgG 100 µL 07-885 PKC τ, active KA 10 µg 14-444
An Update on Ligands for Prostanoid Receptors
, M., et al., Mol. Pharmacol., 60, 36-41 (2001). 60. Kabashima, K., et al., J. Clin. Invest., 109, 883-893 (2002). 61. Wilson, R.J., Br. J. Pharmacol., 138, 84P (2003). 62. Crossley, N.S., Prostaglandins